Verona Eyes New Milestones Ahead, Will The Stock Get A Boost?

Logo RTTNewsRTTNews
2023-03-26 08:26:08  • 2 mins

After a year of remarkable achievements, Verona Pharma plc (VRNA) looks to make 2023 even more momentous.

Verona Pharma is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs.

The lead drug candidate is Ensifentrine, which combines bronchodilator and anti-inflammatory properties in one compound, with the potential to be an effective treatment for chronic obstructive pulmonary disease and other respiratory diseases, including asthma and cystic fibrosis.

Ensifentrine, in nebulized formulation, has been studied in a phase III program for chronic obstructive pulmonary disease maintenance treatment, dubbed ENHANCE, comprising of two trials - ENHANCE-1 and ENHANCE-2.

Continue read on

Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that it has received FDA approval for its generic version of Precedex,...
Logo BenzingaBenzinga
2023-06-09 17:09:00  • 1 min
WASHINGTON (AP) Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimers drug, a key step toward opening insurance...
Logo U.S. News & World ReportU.S. News & World Report
2023-06-09 19:53:01  • 2 mins
(RTTNews) - A panel of independent advisors convened by the Food and Drug Administration is currently meeting to determine whether Leqembi, an Alzheimer's...
Logo NasdaqNasdaq
2023-06-09 19:05:25  • 1 min
The 30,000-square-foot production and distribution facility in Concord will produce ready-to-administer syringes for medical staff.
Personalization is all the rage these days. Whether we're talking about the business of entertainment, food, or clothing, consumers have more options today...
Logo NasdaqNasdaq
2023-06-10 09:39:00  • 1 min
IPH6501 is a first-in-class tetra-specific antibody-based natural killer cell engager therapeutic, based on ANKET platform, targeting CD20 developed for the...
Logo BenzingaBenzinga
2023-06-10 05:00:00  • 2 mins
It has been about a month since the last earnings report for Amicus Therapeutics (FOLD). Shares have added about 8.1% in that time frame, outperforming the...
Logo NasdaqNasdaq
2023-06-09 15:30:33  • 1 min
CEO Jim Clemmer continues to focus the company on high-growth, next-generation products.
Logo The Business JournalsThe Business Journals
2023-06-09 18:19:28  • 1 min
BARTLETT, Tenn. (AP) Next year, North America will see one of the largest and most impressive solar eclipses in living memory. And many people will be...
Logo U.S. News & World ReportU.S. News & World Report
2023-06-09 20:57:36  • 1 min
Human Trial with Novel Glaucoma Treatment Rendered a Clinically Meaningful Efficacy Outcome and Positive Safety and Tolerability Data Today, MediPrint...
Logo BenzingaBenzinga
2023-06-09 00:11:00  • 2 mins
Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide Best News Website or Mobile Service Digital Media Awards Worldwide BRUSSELS...
Logo Channel NewsAsiaChannel NewsAsia
2023-06-09 15:57:29  • 1 min
Health care stocks were mixed premarket Friday as the iShares Biotechnology ETF (IBB) was up 0.3% and the Health Care Select Sector SPDR Fund ( XLV ) was...
Logo NasdaqNasdaq
2023-06-09 13:13:58  • 1 min
Pharma giant AstraZeneca has signed a huge deal with a UK start-up to create treatments for diabetes and other autoimmune diseases. The FTSE 100 firm will...
Logo Daily MailDaily Mail
2023-06-09 20:50:08  • 1 min
Catalent, Inc. CTLT, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release...
Logo BenzingaBenzinga
2023-06-09 20:19:00  • 2 mins
Fintel reports that on June 9, 2023, Stifel upgraded their outlook for Repare Therapeutics ( NASDAQ:RPTX ) from Hold to Buy. Analyst Price Forecast Suggests...
Logo NasdaqNasdaq
2023-06-09 17:52:05  • 1 min
- Partnership aims to understand the care paradigm and associated outcomes for patients with aortic regurgitation - - First study presented by Nick Amoroso,...
Logo BenzingaBenzinga
2023-06-09 22:50:00  • 1 min
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Reata Pharmaceuticals Inc (Symbol:...
Logo NasdaqNasdaq
2023-06-09 19:39:18  • 2 mins
Below is Validea's guru fundamental report for TG THERAPEUTICS INC ( TGTX ). Of the 22 guru strategies we follow, TGTX rates highest using our Quantitative...
Logo NasdaqNasdaq
2023-06-09 20:04:38  • 1 min
The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc AZN and Sanofi SA's SNY nirsevimab has a favorable...
Logo BenzingaBenzinga
2023-06-09 12:07:06  • 1 min
Senator Bernie Sanders urged the U.S. Department of Health and Human Services (HHS) to immediately address the exorbitant cost of Eisai Co Ltd ESALY/ Biogen...
Logo BenzingaBenzinga
2023-06-08 15:27:15  • 1 min